136 related articles for article (PubMed ID: 11430911)
1. Trishomocubanes: novel sigma-receptor ligands modulate amphetamine-stimulated [3H]dopamine release.
Liu X; Nuwayhid S; Christie MJ; Kassiou M; Werling LL
Eur J Pharmacol; 2001 Jun; 422(1-3):39-45. PubMed ID: 11430911
[TBL] [Abstract][Full Text] [Related]
2. Modulation of amphetamine-stimulated (transporter mediated) dopamine release in vitro by sigma2 receptor agonists and antagonists.
Izenwasser S; Thompson-Montgomery D; Deben SE; Chowdhury IN; Werling LL
Eur J Pharmacol; 1998 Apr; 346(2-3):189-96. PubMed ID: 9652359
[TBL] [Abstract][Full Text] [Related]
3. Structure-activity relationships at the monoamine transporters and sigma receptors for a novel series of 9-[3-(cis-3, 5-dimethyl-1-piperazinyl)propyl]carbazole (rimcazole) analogues.
Husbands SM; Izenwasser S; Kopajtic T; Bowen WD; Vilner BJ; Katz JL; Newman AH
J Med Chem; 1999 Oct; 42(21):4446-55. PubMed ID: 10543888
[TBL] [Abstract][Full Text] [Related]
4. Steroids modulate N-methyl-D-aspartate-stimulated [3H] dopamine release from rat striatum via sigma receptors.
Nuwayhid SJ; Werling LL
J Pharmacol Exp Ther; 2003 Sep; 306(3):934-40. PubMed ID: 12750428
[TBL] [Abstract][Full Text] [Related]
5. Sigma2 (sigma2) receptors as a target for cocaine action in the rat striatum.
Nuwayhid SJ; Werling LL
Eur J Pharmacol; 2006 Mar; 535(1-3):98-103. PubMed ID: 16480713
[TBL] [Abstract][Full Text] [Related]
6. Release of [3H]dopamine from guinea pig striatal slices is modulated by sigma1 receptor agonists.
Gonzalez GM; Werling LL
Naunyn Schmiedebergs Arch Pharmacol; 1997 Oct; 356(4):455-61. PubMed ID: 9349631
[TBL] [Abstract][Full Text] [Related]
7. [3H]BIMU-1, a 5-hydroxytryptamine3 receptor ligand in NG-108 cells, selectively labels sigma-2 binding sites in guinea pig hippocampus.
Bonhaus DW; Loury DN; Jakeman LB; To Z; DeSouza A; Eglen RM; Wong EH
J Pharmacol Exp Ther; 1993 Nov; 267(2):961-70. PubMed ID: 8246171
[TBL] [Abstract][Full Text] [Related]
8. Trishomocubane as a scaffold for the development of selective dopamine transporter (DAT) ligands.
Banister SD; Moussa IA; Beinat C; Reynolds AJ; Schiavini P; Jorgensen WT; Kassiou M
Bioorg Med Chem Lett; 2011 Jan; 21(1):38-41. PubMed ID: 21146989
[TBL] [Abstract][Full Text] [Related]
9. Trishomocubanes: novel sigma ligands modulate cocaine-induced behavioural effects.
Liu X; Banister SD; Christie MJ; Banati R; Meikle S; Coster MJ; Kassiou M
Eur J Pharmacol; 2007 Jan; 555(1):37-42. PubMed ID: 17113074
[TBL] [Abstract][Full Text] [Related]
10. Influence of trishomocubanes on sigma receptor binding of N-(1-benzyl-piperidin-4-yl)-4-[123I]iodobenzamide in vivo in the rat brain.
Liu X; Mattner F; Katsifis A; Christie M; Kassiou M
Med Chem; 2005 Jan; 1(1):31-8. PubMed ID: 16789883
[TBL] [Abstract][Full Text] [Related]
11. [3H]RS-23597-190, a potent 5-hydroxytryptamine4 antagonist labels sigma-1 but not sigma-2 binding sites in guinea pig brain.
Bonhaus DW; Loury DN; Jakeman LB; Hsu SA; To ZP; Leung E; Zeitung KD; Eglen RM; Wong EH
J Pharmacol Exp Ther; 1994 Oct; 271(1):484-93. PubMed ID: 7965749
[TBL] [Abstract][Full Text] [Related]
12. Differentiation of sigma ligand-activated receptor subtypes that modulate NMDA-evoked [3H]-noradrenaline release in rat hippocampal slices.
Monnet FP; de Costa BR; Bowen WD
Br J Pharmacol; 1996 Sep; 119(1):65-72. PubMed ID: 8872358
[TBL] [Abstract][Full Text] [Related]
13. N-alkyl substituted analogs of the sigma receptor ligand BD1008 and traditional sigma receptor ligands affect cocaine-induced convulsions and lethality in mice.
Matsumoto RR; McCracken KA; Pouw B; Miller J; Bowen WD; Williams W; De Costa BR
Eur J Pharmacol; 2001 Jan; 411(3):261-73. PubMed ID: 11164383
[TBL] [Abstract][Full Text] [Related]
14. Tolerance in the replacement of the benzhydrylic O atom in 4-[2-(diphenylmethoxy)ethyl]-1-benzylpiperidine derivatives by an N atom: development of new-generation potent and selective N-analogue molecules for the dopamine transporter.
Dutta AK; Xu C; Reith ME
J Med Chem; 1998 Aug; 41(17):3293-7. PubMed ID: 9703474
[TBL] [Abstract][Full Text] [Related]
15. Comparison of binding parameters of sigma 1 and sigma 2 binding sites in rat and guinea pig brain membranes: novel subtype-selective trishomocubanes.
Nguyen VH; Kassiou M; Johnston GA; Christie MJ
Eur J Pharmacol; 1996 Sep; 311(2-3):233-40. PubMed ID: 8891604
[TBL] [Abstract][Full Text] [Related]
16. Sigma(2)-receptor regulation of dopamine transporter via activation of protein kinase C.
Derbez AE; Mody RM; Werling LL
J Pharmacol Exp Ther; 2002 Apr; 301(1):306-14. PubMed ID: 11907188
[TBL] [Abstract][Full Text] [Related]
17. Regulation of [3H]norepinephrine release from guinea pig hippocampus by sigma2 receptors.
Weatherspoon JK; Gonzalez-Alvear GM; Werling LL
Eur J Pharmacol; 1997 May; 326(2-3):133-8. PubMed ID: 9196265
[TBL] [Abstract][Full Text] [Related]
18. Further structurally constrained analogues of cis-(6-benzhydrylpiperidin-3-yl)benzylamine with elucidation of bioactive conformation: discovery of 1,4-diazabicyclo[3.3.1]nonane derivatives and evaluation of their biological properties for the monoamine transporters.
Kolhatkar R; Cook CD; Ghorai SK; Deschamps J; Beardsley PM; Reith ME; Dutta AK
J Med Chem; 2004 Oct; 47(21):5101-13. PubMed ID: 15456254
[TBL] [Abstract][Full Text] [Related]
19. A new approach to the design of sigma-2-selective ligands: synthesis and evaluation of N-[2-(3,4-dichlorophenyl)ethyl]-N-methyl-2-(1- pyrrolidinyl)ethylamine-related polyamines at sigma-1 and sigma-2 receptor subtypes.
de Costa BR; He XS; Dominguez C; Cutts J; Williams W; Bowen WD
J Med Chem; 1994 Jan; 37(2):314-21. PubMed ID: 8295220
[TBL] [Abstract][Full Text] [Related]
20. Inhibition by dizocilpine (MK-801) of striatal dopamine release induced by MPTP and MPP+: possible action at the dopamine transporter.
Clarke PB; Reuben M
Br J Pharmacol; 1995 Jan; 114(2):315-22. PubMed ID: 7881731
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
